Diffuse Intrinsic Pontine Glioma Clinical Trials in St Louis, Missouri

3 studies are recruiting for diffuse intrinsic pontine glioma in St Louis, Missouri right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

    The purpose of this study is to evaluate the investigational oral drug AMXT 1501 in combination with oral eflornithine (DFMO). An investigational drug is one that has not been approved by the U.S. Food \& Drug Administration (FDA), or any other regulatory authorities around the world for use alone …

    Stage
    Phase 1
    Ages
    Up to 26
    Site
    Cardinal Glennon Children's Medical Center, St Louis, Missouri
    Locations
    14 in total
    Run by
    Milton S. Hershey Medical Center

    See if you can join NCT06465199 on ClinicalTrials.gov

  2. PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

    This study will address the question of whether targeting CMV antigens with PEP-CMV can serve as a novel immunotherapeutic approach in pediatric patients with newly-diagnosed high-grade glioma (HGG) or diffuse intrinsic pontine glioma (DIPG) as well as recurrent medulloblastoma (MB). PEP-CMV is a v…

    Stage
    Phase 2
    Ages
    3 to 39
    Site
    St. Louis Children's Hospital, St Louis, Missouri
    Locations
    13 in total
    Run by
    Nationwide Children's Hospital

    See if you can join NCT05096481 on ClinicalTrials.gov

  3. Combination Therapy for the Treatment of Diffuse Midline Gliomas

    This phase II trial determines if the combination of ONC201 with different drugs is effective for treating participants with diffuse midline gliomas (DMGs). Despite years of research, little to no progress has been made to improve outcomes for participants with DMGs, and there are few treatment opt…

    Stage
    Phase 2
    Ages
    2 to 39
    Site
    Washington University in St. Louis, St Louis, Missouri
    Locations
    32 in total
    Run by
    University of California, San Francisco

    See if you can join NCT05009992 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.